BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26861273)

  • 1. Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors.
    Mantoani SP; Chierrito TP; Vilela AF; Cardoso CL; Martínez A; Carvalho I
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26861273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticholinergic activity of 4-hydroxycoumarin derivatives containing substituted benzyl-1,2,3-triazole moiety.
    Bagheri SM; Khoobi M; Nadri H; Moradi A; Emami S; Jalili-Baleh L; Jafarpour F; Homayouni Moghadam F; Foroumadi A; Shafiee A
    Chem Biol Drug Des; 2015 Nov; 86(5):1215-20. PubMed ID: 26010139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
    Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T
    Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease.
    Le-Nhat-Thuy G; Nguyen Thi N; Pham-The H; Dang Thi TA; Nguyen Thi H; Nguyen Thi TH; Nguyen Hoang S; Nguyen TV
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127404. PubMed ID: 32717612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS; Wang XB; Hu XJ; Kong LY
    Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
    Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.
    Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Ramírez L; Viayna E; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Bidon-Chanal A; Huertas O; Dafni T; Luque FJ
    Chem Biol Interact; 2010 Sep; 187(1-3):411-5. PubMed ID: 20167211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
    Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
    Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Biological Evaluation and In Silico Computational Studies of 7-Chloro-4-(1
    Rosado-Solano DN; Barón-Rodríguez MA; Sanabria Florez PL; Luna-Parada LK; Puerto-Galvis CE; Zorro-González AF; Kouznetsov VV; Vargas-Méndez LY
    J Agric Food Chem; 2019 Aug; 67(33):9210-9219. PubMed ID: 31390203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors.
    Cheng ZQ; Song JL; Zhu K; Zhang J; Jiang CS; Zhang H
    Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30134630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
    Manral A; Saini V; Meena P; Tiwari M
    Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
    Wu W; Liang X; Xie G; Chen L; Liu W; Luo G; Zhang P; Yu L; Zheng X; Ji H; Zhang C; Yi W
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30301153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
    Korabecny J; Andrs M; Nepovimova E; Dolezal R; Babkova K; Horova A; Malinak D; Mezeiova E; Gorecki L; Sepsova V; Hrabinova M; Soukup O; Jun D; Kuca K
    Molecules; 2015 Dec; 20(12):22084-101. PubMed ID: 26690394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
    Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
    J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Hybrids of 4-Amino-2,3-polymethylene-quinoline and
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Astakhova TY; Rudakova EV; Proshin AN; Serkov IV; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
    Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
    Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.
    Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ
    Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.